Skip to content

Clinical trials

Phase 3 Seizures trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Phase: Phase 3 Country / region: Japan Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20104
20112
20121
20163
20173
20191
20211
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting4
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Japan Co. Ltd.4
Longboard Pharmaceuticals3
Eisai Co., Ltd.2
Novartis Pharmaceuticals2
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2
Eisai Limited1
SK Life Science, Inc.1
Shire1
UCB Biopharma S.P.R.L.1
UCB Biopharma SRL1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures21
Epilepsy16
Epilepsies, Myoclonic4
Lennox Gastaut Syndrome4
Neurodevelopmental Disorders3
Brain Diseases2
Tuberous Sclerosis2
Angiomyolipoma1
Astrocytoma1
Drug Resistant Epilepsy1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.